▁concentr ates ▁for ▁patients ▁with ▁serious ▁or ▁terminal ▁ill ness es . ▁Tre at ment ▁options ▁with ▁can nab is ▁flower ▁or ▁can nab is ▁res in ▁are ▁not ▁available . ▁ ▁An ▁official ▁can nab idi ol ▁prepar ation ▁( E pid io lex ® ) ▁for ▁rare ▁forms ▁of ▁ep ile ps y ▁was ▁approved ▁by ▁the ▁F DA ▁in ▁June ▁ 2 0 1 8 , ▁and ▁by ▁the ▁European ▁Medic ines ▁Agency ▁in ▁September ▁ 2 0 1 9 . ▁Since ▁then , ▁Swiss ▁ph arma cies ▁are ▁allowed ▁to ▁prepare ▁and ▁disp ense ▁medic inal ▁products ▁containing ▁can nab idi ol ▁as ▁a ▁mag ist ral ▁form ulation ▁and ▁pres cription ▁drug ▁( not ▁subject ▁to ▁the ▁N arc ot ics ▁Act ), ▁in ▁accord ance ▁with ▁current ▁German ▁D rug ▁Code x ▁D AC / NR F ▁and ▁Swiss ▁ph arm ac ope ial ▁standards . ▁ ▁Reform ▁attempts ▁In ▁ 2 0 0 1 , ▁the ▁Swiss ▁federal ▁council ▁committed ▁to ▁implement ▁changes ▁as ▁to ▁dec riminal ization ▁of ▁personal ▁use ▁and ▁possession , ▁and ▁the ▁Parliament ▁was ▁task ed ▁to ▁tender ▁concrete ▁approaches . ▁ ▁An ▁attempt ▁to ▁dec riminal ize ▁possession ▁and ▁consumption ▁of ▁can nab is ▁failed ▁narrow ly ▁in ▁Parliament ▁in ▁ 2 0 0 4 . ▁As ▁a ▁reaction , ▁a ▁popular ▁initi ative ▁(" E id gen ö ss ische ▁Volks init i ative ▁für ▁eine ▁vern ün ft ige ▁Han f - Pol it ik ▁mit ▁wir ksam em